Alexandra Kropotova - Dec 18, 2024 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Alexandra Kropotova
Stock symbol
SABS
Transactions as of
Dec 18, 2024
Transactions value $
$0
Form type
4
Date filed
12/31/2024, 05:49 PM
Previous filing
Nov 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SABS Common Stock Tax liability -9.07K -15.78% 48.4K Dec 18, 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer's common stock ("Common Stock") withheld to satisfy tax withholding requirements on the vesting of the Issuer's restricted stock units ("RSUs").
F2 Includes 21,712 shares of Common Stock and 26,716 shares of Common Stock which remain subject to vesting of RSUs granted under the Issuer's 2021 Equity Incentive Plan, as amended.
F3 Each RSU represents a contingent right to receive one share of Common Stock.